source
- STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trialWith good results from Intellia, the CRISPR field faces the question: How attractive will the one-and-done approach be to patients and doctors?STAT · 4mo ago↗ source
- Endpoints wins Neal Awards for Trump and gene editing coverage, JPM eventEndpoints News was recognized with three 2026 Neal Awards for its coverage of the drug industry's relationship with the Trump administration, a three-part series on the future of CRISPR gene editin…Endpoints · 4mo ago↗ source